Torrent Pharmaceuticals Limited TORNTPHARM.NS
Torrent Pharmaceuticals Limited statistics & valuation
Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value (₹563.18); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Torrent Pharmaceuticals Limited trades at about 77× earnings — above its 10-year norm (10-year range 44.9×–65.5×, median 58.8×).
Shaded band = 10-year range (44.9×–65.5×); dot = today's 77×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Gross margin | 74.4% | 74.5% | 73.6% | 70.1% |
| Operating margin | 25.0% | 25.9% | 24.4% | 22.6% |
| Net margin | 15.7% | 16.9% | 15.7% | 13.2% |
| FCF margin | 17.1% | 17.4% | 26.8% | 19.0% |
| Return on assets | 4.9% | 12.8% | 11.0% | 8.3% |
| Return on equity | 25.8% | 25.2% | 24.2% | 20.1% |
| Debt / equity | 1.39× | 0.16× | 0.23× | 0.40× |
| Current ratio | 1.13 | 1.19 | 1.03 | 0.98 |
Computed from company filings · IN · as of 2026-03-31. Figures in INR. Facts plus Stocktoria's own computed scores — not investment advice.